Susquehanna International Group
LEGN icon

Susquehanna International Group’s Legend Biotech LEGN Stock Holding History

Susquehanna International Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Sell
68,300
-90,900
-57% -$1.73M ﹤0.01% 7345
2025
Q4 		$3.46M Sell
159,200
-215,000
-57% -$6.16M ﹤0.01% 4628
2025
Q3 		$12.2M Buy
374,200
+196,400
+110% +$7.25M ﹤0.01% 2787
2025
Q2 		$6.31M Buy
177,800
+19,500
+12% +$632K ﹤0.01% 3564
2025
Q1 		$5.37M Buy
158,300
+52,500
+50% +$1.88M ﹤0.01% 3529
2024
Q4 		$3.44M Sell
105,800
-43,800
-29% -$1.81M ﹤0.01% 4204
2024
Q3 		$7.29M Buy
149,600
+2,200
+1% +$117K ﹤0.01% 3036
2024
Q2 		$6.53M Sell
147,400
-81,300
-36% -$3.75M ﹤0.01% 3038
2024
Q1 		$12.8M Buy
228,700
+106,800
+88% +$6.44M ﹤0.01% 2290
2023
Q4 		$7.33M Buy
121,900
+98,400
+419% +$6.24M ﹤0.01% 3088
2023
Q3 		$1.58M Sell
23,500
-50,100
-68% -$3.48M ﹤0.01% 5619
2023
Q2 		$5.08M Buy
73,600
+39,600
+116% +$2.59M ﹤0.01% 3507
2023
Q1 		$1.64M Sell
34,000
-31,400
-48% -$1.54M ﹤0.01% 5576
2022
Q4 		$3.26M Buy
65,400
+2,200
+3% +$107K ﹤0.01% 3878
2022
Q3 		$2.58M Sell
63,200
-40,900
-39% -$1.92M ﹤0.01% 4391
2022
Q2 		$5.73M Sell
104,100
-21,000
-17% -$887K ﹤0.01% 2968
2022
Q1 		$4.55M Buy
125,100
+75,300
+151% +$2.98M ﹤0.01% 3793
2021
Q4 		$2.32M Buy
49,800
+29,600
+147% +$1.5M ﹤0.01% 5161
2021
Q3 		$1.02M Buy
20,200
+4,400
+28% +$183K ﹤0.01% 7509
2021
Q2 		$649K Buy
15,800
+7,400
+88% +$252K ﹤0.01% 8926
2021
Q1 		$244K Buy
+8,400
New +$229K ﹤0.01% 11041

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna International Group's LEGN Position: Q1 2026 in Review

Susquehanna International Group increased its Legend Biotech (LEGN) stake by 19% in Q1 2026, buying an estimated $555K and bringing the position to 182,364 shares worth $3.3M. The position accounts for ﹤0.01% of the portfolio, ranked #5072.

Susquehanna International Group first reported a position in LEGN in Q1 2021 and has held it in 16 quarters since. The position peaked at $8.74M in Q2 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Susquehanna International Group held 182,364 shares of Legend Biotech worth $3.3M as of Q1 2026.
  • Susquehanna International Group bought 29,089 Legend Biotech shares in Q1 2026, an estimated $555K.
  • Legend Biotech made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5072 holding.
  • Susquehanna International Group first reported a position in Legend Biotech in Q1 2021 and has held it in 16 quarters since.
  • Susquehanna International Group's Legend Biotech position peaked at $8.74M in Q2 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.